Oncology

  • 6 December 2019
    Analysis

    November’s top news stories

    Eli Lilly and Boehringer Ingelheim started a Phase III clinical trial, EMPULSE, to evaluate whether Jardiance (empagliflozin) improves acute heart failure, and The Janssen Pharmaceutical Companies of Johnson & Johnson...

Close
Close
Close

Go Top